Results 131 to 140 of about 29,741 (152)

Evolution of the lipidome uncovers early changes in adrenoleukodystrophy human cortical and spinal organoids. [PDF]

open access: yesiScience
Ferrer RM   +11 more
europepmc   +1 more source

The X-Linked Adrenoleukodystrophy (X-ALD) and Oxidative Stress

open access: yesJournal of Herbal Pharmacotherapy: Innovations in Clinical and Applied Evidence-based Herbal Medicinals, 2006
Most of the studies indicate that there is as yet no complete cure for X-ALD. However, methods of the treatment seem to slow rather than treat the disease.
Mohamed A Al-Omar
exaly   +2 more sources

Functional overlap between ABCD1 (ALD) and ABCD2 (ALDR) transporters: a therapeutic target for X-adrenoleukodystrophy

open access: yesHuman Molecular Genetics, 2004
X-linked adrenoleukodystrophy (X-ALD) is a severe neurodegenerative disease caused by loss of function of the peroxisomal transporter ABCD1 (ALD), which results in accumulation of very long chain fatty acids (VLCFAs) in organs and serum, central ...
Isidro Ferrer   +2 more
exaly   +2 more sources

Treatment of cerebral adrenoleukodystrophy: allogeneic transplantation and lentiviral gene therapy

open access: yesExpert Opinion on Biological Therapy, 2022
Introduction: Adrenoleukodystrophy (ALD) is an X-linked peroxisomal disorder with an incidence of 1 in 14–17,000 male births, caused by pathogenic variants within the ABCD1 gene.
Ashish Gupta   +2 more
exaly   +2 more sources

Adrenoleukodystrophy (ALD)

Modern Otology and Neurotology, 2021
Makiko Kaga
exaly  

Mutation analysis of the ALD gene in seven Japanese families with X-linked adrenoleukodystrophy

Journal of Human Genetics, 2003
Akira Tsuru, Tatsuro Kondoh, K Tamagawa
exaly  

Home - About - Disclaimer - Privacy